Track the 한국유니온제약 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 한국유니온제약 has published 70 reports. Market capitalisation: €217bn. The latest transaction was disclosed on 26 May 2026 (Purchase). Among the most active insiders: 안희숙. All data is free.
70
Insider Decl.
n/a
Thresholds
n/a
9 ops.
Buy Volume
n/a
6 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,877 of 28,065 companies
19.4
score / 100
Value
25
Quality
14
FCF yld-0.6%
Earn yld-14%
EV/EBITDA·
ROE·
Gross mgn22%
Net mgn-85%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.